What are the guidelines for withholding or managing non‑cardiac medications before coronary angiography?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 12, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Management of Non-Cardiac Medications Before Coronary Angiography

Continue aspirin (ASA) in all patients undergoing coronary angiography, regardless of indication, as it reduces mortality without increasing bleeding risk. 1, 2

Antiplatelet Therapy Management

Aspirin (ASA)

  • Continue chronic ASA therapy through the procedure 3
  • If not on chronic ASA, administer a loading dose orally before the procedure 3
  • ASA continuation is strongly recommended even in patients who may require CABG, as it does not increase perioperative bleeding or transfusion requirements 1

P2Y12 Inhibitors (Clopidogrel, Ticagrelor, Prasugrel)

For Elective Coronary Angiography (Stable CAD):

  • Do NOT routinely pretreat with P2Y12 inhibitors before diagnostic angiography 3
  • Administer clopidogrel 600 mg loading dose in the catheterization laboratory only if PCI is performed 3
  • Clopidogrel is the preferred P2Y12 inhibitor for elective PCI 3

For NSTE-ACS:

  • If angiography expected ≤24 hours: Do NOT pretreat with P2Y12 inhibitors 3
  • If angiography expected >24 hours: Pretreat with P2Y12 inhibitor before the procedure 3
  • Exception: If high suspicion for CABG anatomy, withhold P2Y12 inhibitor even if delay >24 hours 3

If Patient Already on P2Y12 Inhibitor:

  • Continue therapy through diagnostic angiography 2, 4
  • If CABG is planned after angiography, follow specific discontinuation protocols (see below) 1, 2

Timing of P2Y12 Inhibitor Discontinuation Before CABG

Clopidogrel:

  • Ideal interruption: 5 days before elective CABG 1, 2
  • Minimum interruption for semi-urgent CABG: 48-72 hours 1, 2
  • Studies show 3 days may be sufficient to mitigate bleeding risk 3

Ticagrelor:

  • Ideal interruption: 5 days before elective CABG 1
  • Minimum interruption for semi-urgent CABG: 48-72 hours 1
  • For non-cardiac surgery: stop 3-5 days before procedure 5

Prasugrel:

  • Ideal interruption: 7 days before elective CABG 1, 2
  • Minimum interruption for semi-urgent CABG: 5 days 1, 2

Anticoagulation Management

If Patient on Anticoagulation Before Angiography:

Unfractionated Heparin (UFH):

  • Continue through procedure and for at least 48 hours after diagnostic angiography 2, 4
  • If CABG planned: Continue UFH perioperatively 2, 4

Enoxaparin:

  • Continue for duration of hospitalization (up to 8 days) if given before angiography 4
  • If CABG planned: Discontinue 12-24 hours before surgery and transition to UFH 2, 4

Fondaparinux:

  • Continue for duration of hospitalization (up to 8 days) if given before angiography 4
  • If CABG planned: Discontinue 24 hours before surgery and transition to UFH 2, 4

Bivalirudin:

  • May discontinue or continue at 0.25 mg/kg/h for up to 72 hours at physician's discretion 4
  • If CABG planned: Discontinue 3 hours before surgery and transition to UFH 2, 4

GP IIb/IIIa Inhibitors

Before Diagnostic Angiography:

  • If already started, continue through procedure 4
  • Do NOT routinely start before diagnostic angiography 4

If CABG Planned:

  • Discontinue eptifibatide or tirofiban 4 hours before CABG 2, 4

If PCI Performed:

  • Administer for troponin-positive and high-risk patients if not already started 4
  • May omit if bivalirudin used and clopidogrel 300 mg given ≥6 hours earlier 4

Non-Antithrombotic Medications

Beta-Blockers and Other Cardiac Medications

  • Continue all chronic cardiac medications (beta-blockers, ACE inhibitors, ARBs, statins) through the procedure 6
  • These medications should NOT be discontinued for diagnostic coronary angiography 6

Premedication with Sedatives

  • Routine premedication with benzodiazepines (diazepam) and antihistamines (chlorpheniramine) is NOT recommended 7
  • Studies show no benefit for anxiety or pain reduction and may increase local pain 7
  • Intravenous midazolam may be administered during the procedure at operator's discretion 7

Critical Pitfalls to Avoid

  • Never discontinue aspirin before diagnostic angiography - this increases mortality risk without reducing bleeding 1, 2
  • Do not preload P2Y12 inhibitors for elective cases - this unnecessarily exposes patients to bleeding risk if CABG is needed 3
  • Do not delay urgent CABG excessively for P2Y12 washout - experienced surgeons can proceed with 48-72 hours interruption if clinically necessary 1, 2
  • Always transition fondaparinux and enoxaparin to UFH before CABG - direct continuation increases bleeding risk 2, 4

References

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.